GTB-3550 TriKE® Phase I
2015LS167
Phase 2 small_molecule terminated
Quick answer
GTB-3550 TriKE® Phase I for High-risk Myelodysplastic Syndromes is a Phase 2 program (small_molecule) at GT Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GT Biopharma
- Indication
- High-risk Myelodysplastic Syndromes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated